Showing 4 of 4 recruiting trials for “Fibrodysplasia ossificans progressiva”
RecruitingNCT06724562 ↗
IL1 Inhibition in FOP
👨⚕️ Edward Hsiao, MD, PhD, University of California, San Francisco📍 1 site📅 Started Apr 2025View details ↗
RecruitingNCT06089616 ↗
A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva
Saracatinib Trial TO Prevent FOP
👨⚕️ Elisabeth MW Eekhoff, MD, PhD, Amsterdam University Medical Center📍 3 sites📅 Started Aug 2020View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →